“In the 39-week study in dogs, zanubrutinib was administered orally at doses of 10, 30, or 100 mg/kg/day with a 4-week recovery period.”
✓ VerifiedFDA multi-discipline review, p. 27Source ↗
Pivotal GLP studies
6-month rat and 9-month dog oral once-daily studies
“Zanubrutinib was administered once daily to rats and dogs in studies up to 6 months in rats and 9 months in dogs. The studies were conducted using the oral route of administration, which is consistent with the intended clinical route of administration.”
✓ VerifiedFDA multi-discipline review, p. 26Source ↗
Route in tox
Oral
“The studies were conducted using the oral route of administration, which is consistent with the intended clinical route of administration.”
✓ VerifiedFDA multi-discipline review, p. 26Source ↗